News Sentiment

HYL sentiment intelligence

Hyloris Pharmaceuticals SA news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 9 relevant articles
Exchange BRU Belgium
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 4.65 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

85/100 classification confidence.

Company focus 9

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+2.9% over one week, -2.1% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Hyloris Secures New China Licensing Pathway for Maxigesic IV

Market Reaction

Balanced read

60/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 85/100 classification
One-week reaction 2.9% Price confirming higher
Trend fit Trend inactive -2.1% over four weeks
Fair value -41.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 9
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 9
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
GlobeNewswire 4
Market source 2
TipRanks 1
TradingView 1
webull.com.my 1

Event Lens

What the news is about

Classified themes
Market update 7
Regulatory and legal 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-9 of 9